Literature DB >> 27327156

Changes in the expression of voltage-gated sodium channels Nav1.3, Nav1.7, Nav1.8, and Nav1.9 in rat trigeminal ganglia following chronic constriction injury.

Wenhua Xu1, Jun Zhang, Yuanyin Wang, Liecheng Wang, Xuxia Wang.   

Abstract

Voltage-gated sodium channels (VGSCs), especially the tetrodotoxin-sensitive Nav1.3 and Nav1.7, and the tetrodotoxin-resistant Nav1.8 and Nav1.9, have been implicated in acute and chronic neuropathic pain. The aim of this study was to investigate the expression of VGSC Nav1.3, Nav1.7, Nav1.8, and Nav1.9 after nerve injury and their roles in the development of trigeminal neuralgia (TN). We used the infraorbital nerve-chronic constriction injury model of TN in the rat. The time course of changes in the mechanical pain threshold was examined. In addition, real-time PCR and double immunofluorescence staining of VGSC α subunits were used to evaluate messenger RNA and protein expression, respectively, in the trigeminal ganglion. Behavioral tests showed that the mechanical pain threshold decreased significantly 4-42 days after surgery and reached the lowest observed value by day 12. Compared with sham-operated controls, we found that trigeminal ganglion in rats subjected to an infraorbital nerve-chronic constriction injury showed upregulation of Nav1.3 and downregulation of Nav1.7, Nav1.8, and Nav1.9 messenger RNA and protein levels. Our findings suggest that VGSC may participate in the regulation of TN.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27327156     DOI: 10.1097/WNR.0000000000000632

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  11 in total

Review 1.  Sodium channels and pain: from toxins to therapies.

Authors:  Fernanda C Cardoso; Richard J Lewis
Journal:  Br J Pharmacol       Date:  2017-09-02       Impact factor: 8.739

2.  The discovery of a potent Nav1.3 inhibitor with good oral pharmacokinetics.

Authors:  D C Pryde; N A Swain; P A Stupple; C W West; B Marron; C J Markworth; D Printzenhoff; Z Lin; P J Cox; R Suzuki; S McMurray; G J Waldron; C E Payne; J S Warmus; M L Chapman
Journal:  Medchemcomm       Date:  2017-04-28       Impact factor: 3.597

3.  Repressor element 1-silencing transcription factor drives the development of chronic pain states.

Authors:  Fan Zhang; Sylvain Gigout; Yu Liu; Yiying Wang; Han Hao; Noel J Buckley; Hailin Zhang; Ian C Wood; Nikita Gamper
Journal:  Pain       Date:  2019-10       Impact factor: 7.926

4.  SCN11A gene deletion causes sensorineural hearing loss by impairing the ribbon synapses and auditory nerves.

Authors:  Mian Zu; Wei-Wei Guo; Tao Cong; Fei Ji; Shi-Li Zhang; Yue Zhang; Xin Song; Wei Sun; David Z Z He; Wei-Guo Shi; Shi-Ming Yang
Journal:  BMC Neurosci       Date:  2021-03-22       Impact factor: 3.288

5.  Trigeminal neuralgia and genetics: A systematic review.

Authors:  Mari Aaroe Mannerak; Aslan Lashkarivand; Per Kristian Eide
Journal:  Mol Pain       Date:  2021 Jan-Dec       Impact factor: 3.395

6.  Voltage-Gated Sodium Channel Modulation by a New Spider Toxin Ssp1a Isolated From an Australian Theraphosid.

Authors:  Yashad Dongol; Phil M Choi; David T Wilson; Norelle L Daly; Fernanda C Cardoso; Richard J Lewis
Journal:  Front Pharmacol       Date:  2021-12-24       Impact factor: 5.810

Review 7.  The Molecular Basis and Pathophysiology of Trigeminal Neuralgia.

Authors:  QiLiang Chen; Dae Ik Yi; Josiah Nathan Joco Perez; Monica Liu; Steven D Chang; Meredith J Barad; Michael Lim; Xiang Qian
Journal:  Int J Mol Sci       Date:  2022-03-25       Impact factor: 5.923

Review 8.  Pathophysiological roles and therapeutic potential of voltage-gated ion channels (VGICs) in pain associated with herpesvirus infection.

Authors:  Qiaojuan Zhang; Miguel Martin-Caraballo; Shaochung V Hsia
Journal:  Cell Biosci       Date:  2020-05-24       Impact factor: 7.133

9.  Trigeminal neuralgia: An overview from pathophysiology to pharmacological treatments.

Authors:  Eder Gambeta; Juliana G Chichorro; Gerald W. Zamponi
Journal:  Mol Pain       Date:  2020 Jan-Dec       Impact factor: 3.395

Review 10.  Spider Knottin Pharmacology at Voltage-Gated Sodium Channels and Their Potential to Modulate Pain Pathways.

Authors:  Yashad Dongol; Fernanda Caldas Cardoso; Richard J Lewis
Journal:  Toxins (Basel)       Date:  2019-10-29       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.